Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Nanomedicines Revenue 1.4 Market Analysis by Type 1.4.1 Global Nanomedicines Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Nanoparticles 1.4.3 Nanoshells 1.4.4 Nanotubes 1.4.5 Nanodevices 1.4.6 Others 1.5 Market by Application 1.5.1 Global Nanomedicines Market Share by Application: 2020 VS 2026 1.5.2 Hospitals 1.5.3 Clinics 1.5.4 Research Institute 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Nanomedicines Market Perspective (2015-2026) 2.2 Nanomedicines Growth Trends by Regions 2.2.1 Nanomedicines Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Nanomedicines Historic Market Share by Regions (2015-2020) 2.2.3 Nanomedicines Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Nanomedicines Market Growth Strategy 2.3.6 Primary Interviews with Key Nanomedicines Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Nanomedicines Players by Market Size 3.1.1 Global Top Nanomedicines Players by Revenue (2015-2020) 3.1.2 Global Nanomedicines Revenue Market Share by Players (2015-2020) 3.1.3 Global Nanomedicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Nanomedicines Market Concentration Ratio 3.2.1 Global Nanomedicines Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Nanomedicines Revenue in 2019 3.3 Nanomedicines Key Players Head office and Area Served 3.4 Key Players Nanomedicines Product Solution and Service 3.5 Date of Enter into Nanomedicines Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Nanomedicines Historic Market Size by Type (2015-2020) 4.2 Global Nanomedicines Forecasted Market Size by Type (2021-2026) 5 Nanomedicines Breakdown Data by Application (2015-2026) 5.1 Global Nanomedicines Market Size by Application (2015-2020) 5.2 Global Nanomedicines Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Nanomedicines Market Size (2015-2020) 6.2 Nanomedicines Key Players in North America (2019-2020) 6.3 North America Nanomedicines Market Size by Type (2015-2020) 6.4 North America Nanomedicines Market Size by Application (2015-2020) 7 Europe 7.1 Europe Nanomedicines Market Size (2015-2020) 7.2 Nanomedicines Key Players in Europe (2019-2020) 7.3 Europe Nanomedicines Market Size by Type (2015-2020) 7.4 Europe Nanomedicines Market Size by Application (2015-2020) 8 China 8.1 China Nanomedicines Market Size (2015-2020) 8.2 Nanomedicines Key Players in China (2019-2020) 8.3 China Nanomedicines Market Size by Type (2015-2020) 8.4 China Nanomedicines Market Size by Application (2015-2020) 9 Japan 9.1 Japan Nanomedicines Market Size (2015-2020) 9.2 Nanomedicines Key Players in Japan (2019-2020) 9.3 Japan Nanomedicines Market Size by Type (2015-2020) 9.4 Japan Nanomedicines Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Nanomedicines Market Size (2015-2020) 10.2 Nanomedicines Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Nanomedicines Market Size by Type (2015-2020) 10.4 Southeast Asia Nanomedicines Market Size by Application (2015-2020) 11 India 11.1 India Nanomedicines Market Size (2015-2020) 11.2 Nanomedicines Key Players in India (2019-2020) 11.3 India Nanomedicines Market Size by Type (2015-2020) 11.4 India Nanomedicines Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Nanomedicines Market Size (2015-2020) 12.2 Nanomedicines Key Players in Central & South America (2019-2020) 12.3 Central & South America Nanomedicines Market Size by Type (2015-2020) 12.4 Central & South America Nanomedicines Market Size by Application (2015-2020) 13 Key Players Profiles 13.1 Abbott 13.1.1 Abbott Company Details 13.1.2 Abbott Business Overview and Its Total Revenue 13.1.3 Abbott Nanomedicines Introduction 13.1.4 Abbott Revenue in Nanomedicines Business (2015-2020)) 13.1.5 Abbott Recent Development 13.2 GE Healthcare 13.2.1 GE Healthcare Company Details 13.2.2 GE Healthcare Business Overview and Its Total Revenue 13.2.3 GE Healthcare Nanomedicines Introduction 13.2.4 GE Healthcare Revenue in Nanomedicines Business (2015-2020) 13.2.5 GE Healthcare Recent Development 13.3 Johnson & Johnson 13.3.1 Johnson & Johnson Company Details 13.3.2 Johnson & Johnson Business Overview and Its Total Revenue 13.3.3 Johnson & Johnson Nanomedicines Introduction 13.3.4 Johnson & Johnson Revenue in Nanomedicines Business (2015-2020) 13.3.5 Johnson & Johnson Recent Development 13.4 Merck 13.4.1 Merck Company Details 13.4.2 Merck Business Overview and Its Total Revenue 13.4.3 Merck Nanomedicines Introduction 13.4.4 Merck Revenue in Nanomedicines Business (2015-2020) 13.4.5 Merck Recent Development 13.5 Pfizer 13.5.1 Pfizer Company Details 13.5.2 Pfizer Business Overview and Its Total Revenue 13.5.3 Pfizer Nanomedicines Introduction 13.5.4 Pfizer Revenue in Nanomedicines Business (2015-2020) 13.5.5 Pfizer Recent Development 13.6 CombiMatrix 13.6.1 CombiMatrix Company Details 13.6.2 CombiMatrix Business Overview and Its Total Revenue 13.6.3 CombiMatrix Nanomedicines Introduction 13.6.4 CombiMatrix Revenue in Nanomedicines Business (2015-2020) 13.6.5 CombiMatrix Recent Development 13.7 Celgene 13.7.1 Celgene Company Details 13.7.2 Celgene Business Overview and Its Total Revenue 13.7.3 Celgene Nanomedicines Introduction 13.7.4 Celgene Revenue in Nanomedicines Business (2015-2020) 13.7.5 Celgene Recent Development 13.8 Mallinckrodt 13.8.1 Mallinckrodt Company Details 13.8.2 Mallinckrodt Business Overview and Its Total Revenue 13.8.3 Mallinckrodt Nanomedicines Introduction 13.8.4 Mallinckrodt Revenue in Nanomedicines Business (2015-2020) 13.8.5 Mallinckrodt Recent Development 13.9 Sigma-Tau Pharmaceuticals 13.9.1 Sigma-Tau Pharmaceuticals Company Details 13.9.2 Sigma-Tau Pharmaceuticals Business Overview and Its Total Revenue 13.9.3 Sigma-Tau Pharmaceuticals Nanomedicines Introduction 13.9.4 Sigma-Tau Pharmaceuticals Revenue in Nanomedicines Business (2015-2020) 13.9.5 Sigma-Tau Pharmaceuticals Recent Development 13.10 Teva Pharmaceutical 13.10.1 Teva Pharmaceutical Company Details 13.10.2 Teva Pharmaceutical Business Overview and Its Total Revenue 13.10.3 Teva Pharmaceutical Nanomedicines Introduction 13.10.4 Teva Pharmaceutical Revenue in Nanomedicines Business (2015-2020) 13.10.5 Teva Pharmaceutical Recent Development 13.11 Nanosphere 10.11.1 Nanosphere Company Details 10.11.2 Nanosphere Business Overview and Its Total Revenue 10.11.3 Nanosphere Nanomedicines Introduction 10.11.4 Nanosphere Revenue in Nanomedicines Business (2015-2020) 10.11.5 Nanosphere Recent Development 13.12 UCB SA 10.12.1 UCB SA Company Details 10.12.2 UCB SA Business Overview and Its Total Revenue 10.12.3 UCB SA Nanomedicines Introduction 10.12.4 UCB SA Revenue in Nanomedicines Business (2015-2020) 10.12.5 UCB SA Recent Development 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Nanomedicines Key Market Segments Table 2. Key Players Covered: Ranking by Nanomedicines Revenue Table 3. Ranking of Global Top Nanomedicines Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Nanomedicines Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Nanoparticles Table 6. Key Players of Nanoshells Table 7. Key Players of Nanotubes Table 8. Key Players of Nanodevices Table 9. Key Players of Others Table 10. Global Nanomedicines Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 11. Global Nanomedicines Market Size by Regions (US$ Million): 2020 VS 2026 Table 12. Global Nanomedicines Market Size by Regions (2015-2020) (US$ Million) Table 13. Global Nanomedicines Market Share by Regions (2015-2020) Table 14. Global Nanomedicines Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 15. Global Nanomedicines Market Share by Regions (2021-2026) Table 16. Market Top Trends Table 17. Key Drivers: Impact Analysis Table 18. Key Challenges Table 19. Nanomedicines Market Growth Strategy Table 20. Main Points Interviewed from Key Nanomedicines Players Table 21. Global Nanomedicines Revenue by Players (2015-2020) (Million US$) Table 22. Global Nanomedicines Market Share by Players (2015-2020) Table 23. Global Top Nanomedicines Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nanomedicines as of 2019) Table 24. Global Nanomedicines by Players Market Concentration Ratio (CR5 and HHI) Table 25. Key Players Headquarters and Area Served Table 26. Key Players Nanomedicines Product Solution and Service Table 27. Date of Enter into Nanomedicines Market Table 28. Mergers & Acquisitions, Expansion Plans Table 29. Global Nanomedicines Market Size by Type (2015-2020) (Million US$) Table 30. Global Nanomedicines Market Size Share by Type (2015-2020) Table 31. Global Nanomedicines Revenue Market Share by Type (2021-2026) Table 32. Global Nanomedicines Market Size Share by Application (2015-2020) Table 33. Global Nanomedicines Market Size by Application (2015-2020) (Million US$) Table 34. Global Nanomedicines Market Size Share by Application (2021-2026) Table 35. North America Key Players Nanomedicines Revenue (2019-2020) (Million US$) Table 36. North America Key Players Nanomedicines Market Share (2019-2020) Table 37. North America Nanomedicines Market Size by Type (2015-2020) (Million US$) Table 38. North America Nanomedicines Market Share by Type (2015-2020) Table 39. North America Nanomedicines Market Size by Application (2015-2020) (Million US$) Table 40. North America Nanomedicines Market Share by Application (2015-2020) Table 41. Europe Key Players Nanomedicines Revenue (2019-2020) (Million US$) Table 42. Europe Key Players Nanomedicines Market Share (2019-2020) Table 43. Europe Nanomedicines Market Size by Type (2015-2020) (Million US$) Table 44. Europe Nanomedicines Market Share by Type (2015-2020) Table 45. Europe Nanomedicines Market Size by Application (2015-2020) (Million US$) Table 46. Europe Nanomedicines Market Share by Application (2015-2020) Table 47. China Key Players Nanomedicines Revenue (2019-2020) (Million US$) Table 48. China Key Players Nanomedicines Market Share (2019-2020) Table 49. China Nanomedicines Market Size by Type (2015-2020) (Million US$) Table 50. China Nanomedicines Market Share by Type (2015-2020) Table 51. China Nanomedicines Market Size by Application (2015-2020) (Million US$) Table 52. China Nanomedicines Market Share by Application (2015-2020) Table 53. Japan Key Players Nanomedicines Revenue (2019-2020) (Million US$) Table 54. Japan Key Players Nanomedicines Market Share (2019-2020) Table 55. Japan Nanomedicines Market Size by Type (2015-2020) (Million US$) Table 56. Japan Nanomedicines Market Share by Type (2015-2020) Table 57. Japan Nanomedicines Market Size by Application (2015-2020) (Million US$) Table 58. Japan Nanomedicines Market Share by Application (2015-2020) Table 59. Southeast Asia Key Players Nanomedicines Revenue (2019-2020) (Million US$) Table 60. Southeast Asia Key Players Nanomedicines Market Share (2019-2020) Table 61. Southeast Asia Nanomedicines Market Size by Type (2015-2020) (Million US$) Table 62. Southeast Asia Nanomedicines Market Share by Type (2015-2020) Table 63. Southeast Asia Nanomedicines Market Size by Application (2015-2020) (Million US$) Table 64. Southeast Asia Nanomedicines Market Share by Application (2015-2020) Table 65. India Key Players Nanomedicines Revenue (2019-2020) (Million US$) Table 66. India Key Players Nanomedicines Market Share (2019-2020) Table 67. India Nanomedicines Market Size by Type (2015-2020) (Million US$) Table 68. India Nanomedicines Market Share by Type (2015-2020) Table 69. India Nanomedicines Market Size by Application (2015-2020) (Million US$) Table 70. India Nanomedicines Market Share by Application (2015-2020) Table 71. Central & South America Key Players Nanomedicines Revenue (2019-2020) (Million US$) Table 72. Central & South America Key Players Nanomedicines Market Share (2019-2020) Table 73. Central & South America Nanomedicines Market Size by Type (2015-2020) (Million US$) Table 74. Central & South America Nanomedicines Market Share by Type (2015-2020) Table 75. Central & South America Nanomedicines Market Size by Application (2015-2020) (Million US$) Table 76. Central & South America Nanomedicines Market Share by Application (2015-2020) Table 77. Abbott Company Details Table 78. Abbott Business Overview Table 79. Abbott Product Table 80. Abbott Revenue in Nanomedicines Business (2015-2020) (Million US$) Table 81. Abbott Recent Development Table 82. GE Healthcare Company Details Table 83. GE Healthcare Business Overview Table 84. GE Healthcare Product Table 85. GE Healthcare Revenue in Nanomedicines Business (2015-2020) (Million US$) Table 86. GE Healthcare Recent Development Table 87. Johnson & Johnson Company Details Table 88. Johnson & Johnson Business Overview Table 89. Johnson & Johnson Product Table 90. Johnson & Johnson Revenue in Nanomedicines Business (2015-2020) (Million US$) Table 91. Johnson & Johnson Recent Development Table 92. Merck Company Details Table 93. Merck Business Overview Table 94. Merck Product Table 95. Merck Revenue in Nanomedicines Business (2015-2020) (Million US$) Table 96. Merck Recent Development Table 97. Pfizer Company Details Table 98. Pfizer Business Overview Table 99. Pfizer Product Table 100. Pfizer Revenue in Nanomedicines Business (2015-2020) (Million US$) Table 101. Pfizer Recent Development Table 102. CombiMatrix Company Details Table 103. CombiMatrix Business Overview Table 104. CombiMatrix Product Table 105. CombiMatrix Revenue in Nanomedicines Business (2015-2020) (Million US$) Table 106. CombiMatrix Recent Development Table 107. Celgene Company Details Table 108. Celgene Business Overview Table 109. Celgene Product Table 110. Celgene Revenue in Nanomedicines Business (2015-2020) (Million US$) Table 111. Celgene Recent Development Table 112. Mallinckrodt Business Overview Table 113. Mallinckrodt Product Table 114. Mallinckrodt Company Details Table 115. Mallinckrodt Revenue in Nanomedicines Business (2015-2020) (Million US$) Table 116. Mallinckrodt Recent Development Table 117. Sigma-Tau Pharmaceuticals Company Details Table 118. Sigma-Tau Pharmaceuticals Business Overview Table 119. Sigma-Tau Pharmaceuticals Product Table 120. Sigma-Tau Pharmaceuticals Revenue in Nanomedicines Business (2015-2020) (Million US$) Table 121. Sigma-Tau Pharmaceuticals Recent Development Table 122. Teva Pharmaceutical Company Details Table 123. Teva Pharmaceutical Business Overview Table 124. Teva Pharmaceutical Product Table 125. Teva Pharmaceutical Revenue in Nanomedicines Business (2015-2020) (Million US$) Table 126. Teva Pharmaceutical Recent Development Table 127. Nanosphere Company Details Table 128. Nanosphere Business Overview Table 129. Nanosphere Product Table 130. Nanosphere Revenue in Nanomedicines Business (2015-2020) (Million US$) Table 131. Nanosphere Recent Development Table 132. UCB SA Company Details Table 133. UCB SA Business Overview Table 134. UCB SA Product Table 135. UCB SA Revenue in Nanomedicines Business (2015-2020) (Million US$) Table 136. UCB SA Recent Development Table 137. Research Programs/Design for This Report Table 138. Key Data Information from Secondary Sources Table 139. Key Data Information from Primary Sources List of Figures Figure 1. Global Nanomedicines Market Share by Type: 2020 VS 2026 Figure 2. Nanoparticles Features Figure 3. Nanoshells Features Figure 4. Nanotubes Features Figure 5. Nanodevices Features Figure 6. Others Features Figure 7. Global Nanomedicines Market Share by Application: 2020 VS 2026 Figure 8. Hospitals Case Studies Figure 9. Clinics Case Studies Figure 10. Research Institute Case Studies Figure 11. Nanomedicines Report Years Considered Figure 12. Global Nanomedicines Market Size YoY Growth 2015-2026 (US$ Million) Figure 13. Global Nanomedicines Market Share by Regions: 2020 VS 2026 Figure 14. Global Nanomedicines Market Share by Regions (2021-2026) Figure 15. Porter's Five Forces Analysis Figure 16. Global Nanomedicines Market Share by Players in 2019 Figure 17. Global Top Nanomedicines Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nanomedicines as of 2019 Figure 18. The Top 10 and 5 Players Market Share by Nanomedicines Revenue in 2019 Figure 19. North America Nanomedicines Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Europe Nanomedicines Market Size YoY Growth (2015-2020) (Million US$) Figure 21. China Nanomedicines Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Japan Nanomedicines Market Size YoY Growth (2015-2020) (Million US$) Figure 23. Southeast Asia Nanomedicines Market Size YoY Growth (2015-2020) (Million US$) Figure 24. India Nanomedicines Market Size YoY Growth (2015-2020) (Million US$) Figure 25. Central & South America Nanomedicines Market Size YoY Growth (2015-2020) (Million US$) Figure 26. Abbott Total Revenue (US$ Million): 2019 Compared with 2018 Figure 27. Abbott Revenue Growth Rate in Nanomedicines Business (2015-2020) Figure 28. GE Healthcare Total Revenue (US$ Million): 2019 Compared with 2018 Figure 29. GE Healthcare Revenue Growth Rate in Nanomedicines Business (2015-2020) Figure 30. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018 Figure 31. Johnson & Johnson Revenue Growth Rate in Nanomedicines Business (2015-2020) Figure 32. Merck Total Revenue (US$ Million): 2019 Compared with 2018 Figure 33. Merck Revenue Growth Rate in Nanomedicines Business (2015-2020) Figure 34. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 35. Pfizer Revenue Growth Rate in Nanomedicines Business (2015-2020) Figure 36. CombiMatrix Total Revenue (US$ Million): 2019 Compared with 2018 Figure 37. CombiMatrix Revenue Growth Rate in Nanomedicines Business (2015-2020) Figure 38. Celgene Total Revenue (US$ Million): 2019 Compared with 2018 Figure 39. Celgene Revenue Growth Rate in Nanomedicines Business (2015-2020) Figure 40. Mallinckrodt Total Revenue (US$ Million): 2019 Compared with 2018 Figure 41. Mallinckrodt Revenue Growth Rate in Nanomedicines Business (2015-2020) Figure 42. Sigma-Tau Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 43. Sigma-Tau Pharmaceuticals Revenue Growth Rate in Nanomedicines Business (2015-2020) Figure 44. Teva Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018 Figure 45. Teva Pharmaceutical Revenue Growth Rate in Nanomedicines Business (2015-2020) Figure 46. Nanosphere Total Revenue (US$ Million): 2019 Compared with 2018 Figure 47. Nanosphere Revenue Growth Rate in Nanomedicines Business (2015-2020) Figure 48. UCB SA Total Revenue (US$ Million): 2019 Compared with 2018 Figure 49. UCB SA Revenue Growth Rate in Nanomedicines Business (2015-2020) Figure 50. Bottom-up and Top-down Approaches for This Report Figure 51. Data Triangulation Figure 52. Key Executives Interviewed

Abbott GE Healthcare Johnson & Johnson Merck Pfizer CombiMatrix Celgene Mallinckrodt Sigma-Tau Pharmaceuticals Teva Pharmaceutical Nanosphere UCB SA